carbamates has been researched along with Congenital Zika Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morales Vasquez, D | 1 |
| Park, JG | 1 |
| Ávila-Pérez, G | 1 |
| Nogales, A | 1 |
| de la Torre, JC | 1 |
| Almazan, F | 1 |
| Martinez-Sobrido, L | 1 |
| Tong, X | 1 |
| Smith, J | 1 |
| Bukreyeva, N | 1 |
| Koma, T | 1 |
| Manning, JT | 1 |
| Kalkeri, R | 1 |
| Kwong, AD | 1 |
| Paessler, S | 1 |
2 other studies available for carbamates and Congenital Zika Syndrome
| Article | Year |
|---|---|
Identification of Inhibitors of ZIKV Replication.
Topics: A549 Cells; Animals; Antiviral Agents; Apoptosis; Azauridine; Biphenyl Compounds; Carbamates; Cell S | 2020 |
Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens.
Topics: Animals; Antiviral Agents; Carbamates; Cell Line; Chlorocebus aethiops; Ebolavirus; Humans; IMP Dehy | 2018 |